Cancers
📧 Sign up to get email alerts when something new happens for Cancers.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations [Phase 2]
Phase 2 trial update on secured access to vemurafenib for patients with tumors harboring BRAF alterations; the study is currently active but…
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating whether N-acetylcysteine can prevent cisplatin-induced toxicities in cancer patients.
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency [Phase 2]
Phase 2 trial of LY2606368 (Prexasertib) in patients with solid tumors exhibiting replicative stress or homologous recombination deficiency …
-
CLINICAL_TRIALS trial_result · 2021-11-05Clinical Trial Update: A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 dose-escalation trial of AEB1102 in patients with advanced solid tumors completed.
-
CLINICAL_TRIALS trial_result · 2021-04-22Clinical Trial Update: RADVAX: A Stratified Phase I Trial of Pembrolizumab With Hypofractionated Radiotherapy in Patients With Advanced and Metastatic Cancers [Phase 1]
Phase I trial evaluating pembrolizumab combined with hypofractionated radiotherapy in patients with advanced/metastatic cancers; study compl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea [Phase 2, Phase 3]
Phase 2/3 trial for fentanyl sublingual spray in exercise-induced breakthrough dyspnea in advanced cancers has completed with posted results…
-
CLINICAL_TRIALS trial_result · 2020-08-26Clinical Trial Update: Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma [Phase 2]
A Phase 2 trial evaluating bevacizumab and lapatinib in children with recurrent or refractory ependymoma has been completed with results pos…
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: 4SCAR-CD44v6 T Cell Therapy Targeting Cancer [Phase 1, Phase 2]
Clinical trial update on 4SCAR-CD44v6 T cell therapy targeting cancers that are CD44v6 positive, spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating Aza-SAHA-GBM with autologous stem cell transplant for refractory lymphoma completed.
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor [Phase 2]
Phase 2 pilot trial evaluating hyperthermic intraperitoneal perfusion (HIPEC) for adolescents and young adults with desmoplastic small round…
-
CLINICAL_TRIALS research · 2016-06-09Clinical Trial Update: Iatrogenic Effects of Treatment for Childhood Cancer Constitution of a Biological Samples Bank
Clinical trial update focusing on iatrogenic effects of childhood cancer treatments and the establishment of a biological samples bank.
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: Palliative Care and Symptom Management for the Pediatric Oncology Patient
This completed trial update reports on palliative care and symptom management strategies for children with cancer. The study status indicate…
-
CLINICAL_TRIALS research · 2014-07-14Clinical Trial Update: Patient-Reported Outcomes Version of Common Terminology Criteria (CTCPRO) Cognitive Debriefing
This update reports progress on cognitive debriefing for CTCPRO, a patient-reported outcomes version of CTCAE used to assess cancer-related …